Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Northwest Biotherapeutics Inc (NWBO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.485 +0.008    +1.68%
27/04 - Closed. Currency in USD ( Disclaimer )
After Hours
0.481
-0.004
-0.845%
5:59:52 - Delayed Data
  • Volume: 1,493,803
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.459 - 0.490
Type:  Equity
Market:  United States
Northwest Biotherapeutics 0.485 +0.008 +1.68%

Northwest Biotherapeutics Inc Company Profile

 
Get an in-depth profile of Northwest Biotherapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

-

Equity Type

ORD

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

Contact Information

Address 4800 Montgomery Lane Suite 800
Bethesda, 20814
United States
Phone 240 497 9024
Fax -

Top Executives

Name Age Since Title
Linda F. Powers 65 2007 Chairperson, CEO, President, CFO & Chief Accounting Officer
Alton L. Boynton 76 1998 Founder, Chief Scientific Officer, Secretary & Director
Steven S. Brem - 2005 Member of Clinical Advisory Board
J. Cofer Black 74 2016 Independent Director
Tom Mikkelsen - 2005 Member of Clinical Advisory Board
Navid Malik 55 2012 Independent Director
Henry Brem 71 2005 Member of Clinical Advisory Board
Darell D. Bigner - 2005 Member of Clinical Advisory Board
Linda M. Liau 57 2005 Member of Scientific Advisory Board
Jerome Galon - - Member of Scientific Advisory Board
Samir N. Khleif 60 - Member of Scientific Advisory Board
Martin Cheever 80 - Member of the Scientific Advisory Board
John F. Smyth - - Member of Scientific Advisory Board
Pat Sarma - 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NWBO Comments

Write your thoughts about Northwest Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email